2m 2m 2m 2m 2m 2m 2m
Immucell (ICCC)
NASDAQ
$10.24-$0.010 (-0.10%)
Price as of Oct 23, 2026 4:10 PM EDT- $93.1MMarket Cap
- 68.59%1-Year Change
- BiotechnologyIndustry
Immucell (ICCC)
$10.24-$0.010 (-0.10%)
ICCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.25 | ||
Change | -$0.19 (-1.82%) | ||
Open | $10.36 | ||
High | $10.37 | ||
Low | $10.19 | ||
Previous Close | $10.44 | ||
Volume | 11,335 | ||
30-Day Average Volume | 9,318 | ||
1-Week Change | -4.65% | ||
1-Month Change | 2.60% | ||
1-Year Change | 68.59% | ||
3-Year Change | 126.27% | ||
5-Year Change | 15.04% | ||
Fundamentals | |||
Shares Outstanding | 9.1M | ||
Total Assets | $46.6M | ||
Market Cap | $93.1M | ||
Enterprise Value | $92.5M | ||
Period: QTR TTM FY | |||
Revenue | $7.2M | ||
Net Income | $100,000.00 | ||
Free Cash Flow | $2.3M | ||
EBIT | $145,950.00 | ||
EBITDA | $145,950.00 | ||
Net Working Capital | $16.6M | ||
EPS | $0.20 | ||
Enterprise Value/EBITDA | 634 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 3 | ||
P/E | 51 | ||
PEG | -11 | ||
Price/Free Cash Flow | 41 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue